Merial Adds Recombitek Equine Influenza Virus Vaccine to its Line

Horse Vaccines

On Saturday, Dec. 2, Merial announced the addition of Recombitek Equine Influenza Virus vaccine to its recombinant vaccine line--the first and only equine influenza vaccine in the United States that uses canarypox-vectored technology. Recombitek Equine Influenza Virus vaccine is proven against a recent, highly virulent American strain of equine influenza (N/5/03) and helps stop the spread of influenza by eliminating viral shedding.

"Merial is committed to providing innovative vaccine technology," said Frank Hurtig, DVM, MBA, associate director of equine veterinary medical affairs for Merial Ltd. "The canarypox vector enables this to be the first vaccine demonstrated to stimulate both a protective cell-mediated as well as humoral immune response to equine influenza. In addition, this protection was proven in the face of a highly virulent and very recent American strain of flu.

"This vaccine also stopped viral shedding, which is critical because on average, a horse sick with influenza can infect up to 10 other horses," continued Hurtig. "The canarypox vector takes veterinary medicine beyond traditional vaccine to help veterinarians and horse owners safeguard horses against this highly contagious virus with a convenient intramuscular administration."

Nearly all horses exposed to influenza become infected, although nearly 20% might show no clinical signs of the disease. Infected horses, whether or not they have signs of influenza, can shed the virus, expose other horses to the illness, and spread infection. It often take two weeks or longer for a healthy, adult horse to recover from an influenza infection, but it can be fatal for older animals or young foals. Influenza also is a leading cause of respiratory disease in horses.

Recombitek Equine Influenza Virus injectable vaccine has demonstrated a strong immune response even against a highly virulent, current American threat like N/5/03 in a controlled study. The canarypox-vectored vaccine technology uses only the influenza proteins that are needed to stimulate immunity. In addition, the vaccine also is safe enough to be administered to foals as young as four months of age.

"Providing a quick, strong immune response for more susceptible horses while eliminating the flu virus shedding has been a challenge for the entire industry," Hurtig says. "This technology will help horse owners keep their animals healthy."

2004-2012 Horse Tack Review

 Horse Tack Reviews
 Submit Your Own Review!
 Search Review Database
 All Reader Reviews
 Staff Reviews
 Submit a Product for Review

 English Tack Reviews
 Dressage Saddles
 Jumping Saddles
 Close Contact Saddles
 All Purpose Saddles
 English Saddle Fittings/Pads
 English Bridles
 English Bridle Accessories
 English Show Apparel
 English Casual Apparel
 English Chaps/Boots/Helmets
 English Miscellaneous

 Western Tack Reviews
 Barrel Saddles
 Reining Saddles
 Roping Saddles
 Show Saddles
 Trail Saddles
 Western Saddle Fittings/Pads
 Western Bridles
 Western Bridle Accessories
 Western Show Apparel
 Western Casual Apparel
 Western Chaps/Boots/Hats
 Western Miscellaneous

 Horse Gear Reviews
 Horse Boots and Wraps
 Horse Health and Well Being
 Horse Apparel
 Horse Treats
 Horse Miscellaneous

 Barn & Stable Reviews
 Fly Control
 Grooming Equipment
 Stable Accessories
 Tack Room
 Training Equipment
 Barn and Stable Misc

 Barn and Stable Articles
 English Articles
 Feature and Misc Articles
 Grooming Articles
 Horse Care & Health Articles
 Horse Related Gift Articles
 News and Events
 Training Articles
 Western Articles

 Other Features
 About Us / Contact Information
 Articles & Subjects By Date
 Article Archives
 Join Our Mailing List
 Privacy Policy